coronavirus vaccine Archives -

News/ News/ Patients

Safety of mRNA COVID-19 jabs backed, despite myocarditis cases

Phil Taylor BioNTech, coronavirus vaccine, COVID-19, Moderna, Pfizer, safety, US 0 Comment

As US and EU health regulators review cases of heart inflammation seen in young people administered mRNA-based COVID-19

Safety of mRNA COVID-19 jabs backed, despite myocarditis cases

https://pharmaphorum.com/news/safety-of-mrna-covid-19-jabs-backed-despite-myocarditis-cases/

People wearing a face masks to protecting themself because of epidemic in China. Selective Focus. Concept of coronavirus quarantine.

News/ News/ Patients

UK says Pfizer, AZ COVID-19 vaccines work against Indian variant

Phil Taylor AstraZeneca, BioNTech, coronavirus, coronavirus vaccine, COVID-19, Pfizer, Public Health England, UK 0 Comment

People who have received two doses of the AstraZeneca or Pfizer/BioNTech COVID-19 vaccines have good protection against the

UK says Pfizer, AZ COVID-19 vaccines work against Indian variant

https://pharmaphorum.com/news/uk-says-pfizer-az-covid-19-vaccines-work-against-indian-variant/

News/ News/ Patients

UK booster trial will test value of third COVID jab dose

Phil Taylor AstraZeneca, BioNTech, coronavirus, coronavirus vaccine, COVID-19, CureVac, Janssen, Moderna, Novavax, Pfizer, UK, Valneva 0 Comment

All seven COVID-19 vaccines ordered by the UK government will be tested in a new trial that will

UK booster trial will test value of third COVID jab dose

https://pharmaphorum.com/news/uk-booster-trial-will-test-value-of-third-covid-jab-dose/

News/ News/ R&D

Medicago, GSK’s plant-made COVID jab clears phase 2

Phil Taylor coronavirus, coronavirus vaccine, COVID-19, GlaxoSmithKline, Medicago 0 Comment

Canadian biotech Medicago has the data it was hoping for from a phase 2 trial of its COVID-19

Medicago, GSK’s plant-made COVID jab clears phase 2

https://pharmaphorum.com/news/medicago-gsks-plant-made-covid-jab-clears-phase-2/

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

News/ News/ Patients

EMA panel probes heart inflammation with Pfizer/BioNTech COVID vaccine

Phil Taylor BioNTech, coronavirus, coronavirus vaccine, COVID-19, Pfizer, pharmacovigilance, safety 0 Comment

A review of side effects reported with coronavirus vaccines by the EMA’s safety committee has uncovered cases of

EMA panel probes heart inflammation with Pfizer/BioNTech COVID vaccine

https://pharmaphorum.com/news/ema-panel-probes-heart-inflammation-with-pfizer-biontech-vaccine/

News/ News/ Sales and Marketing

Pfizer says COVID-19 jab could rake in $26bn this year

Phil Taylor coronavirus, coronavirus vaccine, COVID-19, Financial, Pfizer 0 Comment

Pfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it

Pfizer says COVID-19 jab could rake in $26bn this year

https://pharmaphorum.com/news/pfizer-says-covid-19-jab-could-rake-in-26bn-this-year/

Market Access/ News/ News

FDA pens stinging report on Emergent COVID vaccine plant

Phil Taylor AstraZeneca, coronavirus, coronavirus vaccine, COVID-19, Emergent BioSolutions, fda, Johnson & Johnson, manufacturing 0 Comment

Emergent BioSolutions’ difficult month has been made worse by an FDA report into its facility in Baltimore, which

FDA pens stinging report on Emergent COVID vaccine plant

https://pharmaphorum.com/news/fda-pens-stinging-report-on-emergent-covid-vaccine-plant/

News/ News/ Sales and Marketing

EU orders another 100m doses of Pfizer/BioNTech COVID jab

Phil Taylor BioNTech, coronavirus, coronavirus vaccine, COVID-19, EU, Pfizer 0 Comment

The EU has continued a refocus of its COVID-19 vaccination drive on mRNA shots, ordering another 100 million

EU orders another 100m doses of Pfizer/BioNTech COVID jab

https://pharmaphorum.com/news/eu-orders-another-100m-doses-of-pfizer-biontech-covid-jab/

News/ News/ Patients

Update: J&J COVID vaccine rollout paused as clot concerns spread

Phil Taylor coronavirus, coronavirus vaccine, COVID-19, fda, Janssen, Johnson & Johnson, US 0 Comment

US health authorities have recommended pausing dosing with Johnson & Johnson’s COVID-19 vaccine as they investigate cases of

Update: J&J COVID vaccine rollout paused as clot concerns spread

https://pharmaphorum.com/news/us-seeks-halt-on-jj-covid-vaccine-rollout-as-clot-concerns-spread/

Trending

coronavirus vaccine

Login